HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus

ABSTRACT Objectives: Evaluate the celiac disease (CD) markers, within the scope of its screening, in a pediatric population with diagnosis of type 1 diabetes (T1D) at Hospital de Braga (HB) and determine the prevalence of CD in the sample. Reflect on CD screening algorithm applied in this pediatric population. Subjects and methods: Retrospective observational study with 94 patients diagnosed with T1D at age 10 years or younger, followed up at the HB Outpatient Diabetology Consultation, including those referred from other hospitals. Record of clinical information, IgA anti-transglutaminase and anti-endomysium and HLA DQ2/DQ8 haplotypes. Results: We obtained positive serological test for CD in 4 patients. This test had 100% sensitivity and specificity. The prevalence of CD was 4.3% (n = 4). Positive HLA screening in 84.6% of patients, with both sensitivity and negative predictive value of 100% and specificity of 16.67%. Diagnosis of CD was made on average 3.40 ± 3.32 years after the diagnosis of TD1. All cases of CD registered non-gastrointestinal manifestations, none had gastrointestinal symptoms. Conclusion: This study proved that there is a higher prevalence of CD in pediatric population with TD1, when compared to general population, and clarified the importance of CD screening. Furthermore, it was observed that serological screening for CD antibodies is an excellent screening test and HLA typing, although not the most suitable first line test, can be useful in excluding the possibility of patients with T1D developing CD.

Saved in:
Bibliographic Details
Main Authors: Oliveira,Diana Rita, Rebelo,Joana Freitas, Maximiano,Cristiana, Gomes,Maria Miguel, Martins,Vânia, Meireles,Carla, Antunes,Henedina, Martins,Sofia
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000200229
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972022000200229
record_format ojs
spelling oai:scielo:S2359-399720220002002292022-05-10HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitusOliveira,Diana RitaRebelo,Joana FreitasMaximiano,CristianaGomes,Maria MiguelMartins,VâniaMeireles,CarlaAntunes,HenedinaMartins,Sofia Type 1 diabetes celiac disease HLA transglutaminase pediatric age ABSTRACT Objectives: Evaluate the celiac disease (CD) markers, within the scope of its screening, in a pediatric population with diagnosis of type 1 diabetes (T1D) at Hospital de Braga (HB) and determine the prevalence of CD in the sample. Reflect on CD screening algorithm applied in this pediatric population. Subjects and methods: Retrospective observational study with 94 patients diagnosed with T1D at age 10 years or younger, followed up at the HB Outpatient Diabetology Consultation, including those referred from other hospitals. Record of clinical information, IgA anti-transglutaminase and anti-endomysium and HLA DQ2/DQ8 haplotypes. Results: We obtained positive serological test for CD in 4 patients. This test had 100% sensitivity and specificity. The prevalence of CD was 4.3% (n = 4). Positive HLA screening in 84.6% of patients, with both sensitivity and negative predictive value of 100% and specificity of 16.67%. Diagnosis of CD was made on average 3.40 ± 3.32 years after the diagnosis of TD1. All cases of CD registered non-gastrointestinal manifestations, none had gastrointestinal symptoms. Conclusion: This study proved that there is a higher prevalence of CD in pediatric population with TD1, when compared to general population, and clarified the importance of CD screening. Furthermore, it was observed that serological screening for CD antibodies is an excellent screening test and HLA typing, although not the most suitable first line test, can be useful in excluding the possibility of patients with T1D developing CD.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.66 n.2 20222022-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000200229en10.20945/2359-3997000000457
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Oliveira,Diana Rita
Rebelo,Joana Freitas
Maximiano,Cristiana
Gomes,Maria Miguel
Martins,Vânia
Meireles,Carla
Antunes,Henedina
Martins,Sofia
spellingShingle Oliveira,Diana Rita
Rebelo,Joana Freitas
Maximiano,Cristiana
Gomes,Maria Miguel
Martins,Vânia
Meireles,Carla
Antunes,Henedina
Martins,Sofia
HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
author_facet Oliveira,Diana Rita
Rebelo,Joana Freitas
Maximiano,Cristiana
Gomes,Maria Miguel
Martins,Vânia
Meireles,Carla
Antunes,Henedina
Martins,Sofia
author_sort Oliveira,Diana Rita
title HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
title_short HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
title_full HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
title_fullStr HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
title_full_unstemmed HLA DQ2/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
title_sort hla dq2/dq8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus
description ABSTRACT Objectives: Evaluate the celiac disease (CD) markers, within the scope of its screening, in a pediatric population with diagnosis of type 1 diabetes (T1D) at Hospital de Braga (HB) and determine the prevalence of CD in the sample. Reflect on CD screening algorithm applied in this pediatric population. Subjects and methods: Retrospective observational study with 94 patients diagnosed with T1D at age 10 years or younger, followed up at the HB Outpatient Diabetology Consultation, including those referred from other hospitals. Record of clinical information, IgA anti-transglutaminase and anti-endomysium and HLA DQ2/DQ8 haplotypes. Results: We obtained positive serological test for CD in 4 patients. This test had 100% sensitivity and specificity. The prevalence of CD was 4.3% (n = 4). Positive HLA screening in 84.6% of patients, with both sensitivity and negative predictive value of 100% and specificity of 16.67%. Diagnosis of CD was made on average 3.40 ± 3.32 years after the diagnosis of TD1. All cases of CD registered non-gastrointestinal manifestations, none had gastrointestinal symptoms. Conclusion: This study proved that there is a higher prevalence of CD in pediatric population with TD1, when compared to general population, and clarified the importance of CD screening. Furthermore, it was observed that serological screening for CD antibodies is an excellent screening test and HLA typing, although not the most suitable first line test, can be useful in excluding the possibility of patients with T1D developing CD.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000200229
work_keys_str_mv AT oliveiradianarita hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT rebelojoanafreitas hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT maximianocristiana hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT gomesmariamiguel hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT martinsvania hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT meirelescarla hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT antuneshenedina hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
AT martinssofia hladq2dq8haplotypesandantitransglutaminaseantibodiesasceliacdiseasemarkersinapediatricpopulationwithtype1diabetesmellitus
_version_ 1756441496124391424